Literature DB >> 14727807

Detection of early secretory antigenic target-6 antibody for diagnosis of tuberculosis in non-human primates.

Ganga V Kanaujia1, Manuel A Garcia, Donna M Bouley, Robert Peters, Maria Laura Gennaro.   

Abstract

Tuberculosis is one of the most economically devastating, zoonotic infections of captive non-human primates. The limitations of the tuberculin skin test, which is currently used to diagnose tuberculosis in living non-human primates, make it necessary to find new, simple, and economical diagnostic methods. We describe use of an enzyme-linked immunoassay to detect IgG antibodies against early secretory antigenic target (ESAT)-6, a small protein secreted by virulent tubercle bacilli, in paired (pre- and post-outbreak) sera from 57 non-human primates involved in an outbreak of Mycobacterium bovis infection in a research colony. Of 25 animals with tuberculosis lesions at necropsy, 22 (88%) had high serum levels of the ESAT-6 antibody. The ESAT-6 antibody was found in 16% (5/32) of post-outbreak sera from animals in which tuberculosis could not be confirmed at necropsy. The strong association between the ESAT-6 antibody and tuberculosis in non-human primates documented in this study, together with the robustness of the serologic assay, make the ESAT-6 ELISA a valuable tool for diagnosis of tuberculosis in captive non-human primates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14727807

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  6 in total

1.  Recognition of ESAT-6 sequences by antibodies in sera of tuberculous nonhuman primates.

Authors:  G V Kanaujia; S Motzel; M A Garcia; P Andersen; M L Gennaro
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Colonization with nontuberculous mycobacteria is associated with positive tuberculin skin test reactions in the common marmoset (Callithrix jacchus).

Authors:  Lynn M Wachtman; Andrew D Miller; DongLing Xia; Elizabeth H Curran; Keith G Mansfield
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

3.  LipC (Rv0220) is an immunogenic cell surface esterase of Mycobacterium tuberculosis.

Authors:  Guomiao Shen; Krishna Singh; Dinesh Chandra; Carole Serveau-Avesque; Damien Maurin; Stéphane Canaan; Rupak Singla; Digambar Behera; Suman Laal
Journal:  Infect Immun       Date:  2011-10-28       Impact factor: 3.441

4.  PrimaTB STAT-PAK assay, a novel, rapid lateral-flow test for tuberculosis in nonhuman primates.

Authors:  Konstantin P Lyashchenko; Rena Greenwald; Javan Esfandiari; David Greenwald; Carol A Nacy; Susan Gibson; Peter J Didier; Marc Washington; Peter Szczerba; Sherri Motzel; Larry Handt; John M Pollock; James McNair; Peter Andersen; Jan A M Langermans; Frank Verreck; Sean Ervin; Frank Ervin; Candace McCombs
Journal:  Clin Vaccine Immunol       Date:  2007-07-25

5.  Field evaluation of a blood based test for active tuberculosis in endemic settings.

Authors:  Aasia Khaliq; Resmi Ravindran; Syed Fahadulla Hussainy; Viwanathan V Krishnan; Atiqa Ambreen; Noshin Wasim Yusuf; Shagufta Irum; Abdul Rashid; Muhammad Jamil; Fareed Zaffar; Muhammad Nawaz Chaudhry; Puneet K Gupta; Muhammad Waheed Akhtar; Imran H Khan
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

6.  Serodiagnostic efficacy of Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex, ESAT-6, and CFP-10 in patients with active tuberculosis.

Authors:  Gavish Kumar; Pradeep Kumar Dagur; Prashant Kumar Singh; Hari Shankar; Virendra S Yadav; Vishwa M Katoch; Bharat Bajaj; Rajesh Gupta; Utpal Sengupta; Beenu Joshi
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-01-05       Impact factor: 4.291

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.